Evolent Health Enters Material Definitive Agreement

TL;DR

EVH signed a big deal, could mean new money or debt.

AI Summary

Evolent Health, Inc. entered into a material definitive agreement on December 6, 2024. This filing also indicates the creation of a direct financial obligation or an obligation under an off-balance sheet arrangement for the registrant. Specific details of the agreement and financial obligations are not provided in this excerpt.

Why It Matters

This filing signals a significant new contract or financial commitment for Evolent Health, which could impact its future financial performance and strategic direction.

Risk Assessment

Risk Level: medium — The filing indicates a material definitive agreement and potential financial obligations, which inherently carry some level of risk until more details are disclosed.

Key Players & Entities

• Evolent Health, Inc. (company) — Registrant
• December 6, 2024 (date) — Date of earliest event reported

FAQ

Key Financial Figures

• $0.01 — tock of Evolent Health, Inc., par value $0.01 per share EVH New York Stock Exchange
• $50.0 million — an aggregate principal amount equal to $50.0 million (the " Priority ABL Incremental Facilit
• $125.0 million — an aggregate principal amount equal to $125.0 million (the " 2024-A Delayed Draw Term Loan Fa
• $75.0 million — an aggregate principal amount equal to $75.0 million (the " 2024-B Delayed Draw Term Loan Fa

Filing Documents

• evh-20241206.htm (8-K) — 37KB
• a2024126exhibit101.htm (EX-10.1) — 1819KB
• 0001628908-24-000117.txt ( ) — 2241KB
• evh-20241206.xsd (EX-101.SCH) — 2KB
• evh-20241206_lab.xml (EX-101.LAB) — 22KB
• evh-20241206_pre.xml (EX-101.PRE) — 13KB
• evh-20241206_htm.xml (XML) — 3KB

01 - Entry Into a Material Definitive Agreement

Item 1.01 - Entry Into a Material Definitive Agreement. Amendment No. 3 to Credit Agreement On December 6, 2024 (the " Closing Date "), Evolent Health, Inc. (the " Company ") and EVH LLC entered into Amendment No. 3 (" Amendment No. 3 ") to the Credit Agreement, dated as of August 1, 2022, by and between the Lenders party thereto, EVH LLC, as the Administrative Borrower, the other borrowers party thereto, the Company, as the Parent, each other Guarantor party thereto, Ares Capital Corporation (" Ares "), as Administrative Agent, and ACF Finco I LP, as Collateral Agent and Revolving Agent (as amended by that certain Amendment No. 1 dated as of January 20, 2023 and that certain Amendment No. 2 dated as of December 5, 2023, the " Existing Credit Agreement "; the Existing Credit Agreement, as amended by Amendment No. 3, the " Credit Agreement ") that provided new secured debt financing in the form of (i) additional commitments under EVH LLC's existing asset-based revolving credit facility in an aggregate principal amount equal to $50.0 million (the " Priority ABL Incremental Facility "), (ii) a new delayed draw term loan facility in an aggregate principal amount equal to $125.0 million (the " 2024-A Delayed Draw Term Loan Facility "), and (iii) a new delayed draw term loan facility in an aggregate principal amount equal to $75.0 million (the " 2024-B Delayed Draw Term Loan Facility " and together with the Priority ABL Incremental Facility and the 2024-A Delayed Draw Term Loan Facility, the " Committed Facilities "), and effected certain amendments to the Existing Credit Agreement. All loans under the Credit Agreement (including loans under the Committed Facilities and loans outstanding under the Existing Credit Agreement) (collectively, the " Loans ") will mature on the date that is the earliest of (a) the fifth anniversary of the Closing Date, (b) the date on which the commitments are voluntarily terminated pursuant to the terms of the Credit Agreement, (c) the d

03 - Creation of a Direct Financial Obligation

Item 2.03 - Creation of a Direct Financial Obligation. The description of Amendment No. 3 in Item 1.01 of this Form 8-K is incorporated by reference into this Item 2.03.

01. Financial Statements and Exhibits

Item 9.01. Financial Statements and Exhibits. Exhibit No. Description 10.1 Amendment No. 3, dated as of December 6, 2024, to the Credit Agreement, dated as of August 1, 2022, and amended on January 20, 2023 and December 5, 2023, by the Lenders party thereto, Evolent Heath, LLC, as the Administrative Borrower, the other borrowers party thereto, the Company, as the Parent, each other Guarantor party thereto, Ares Capital Corporation, as Administrative Agent, and ACT Finco I LP, as Collateral Agent and Revolving Agent. 104 The cover page from this Current Report on Form 8-K, formatted as Inline XBRL.

SIGNATURES

SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. Date: December 11, 2024 EVOLENT HEALTH, INC. By: /s/ Jonathan Weinberg Name: Jonathan Weinberg Title: General Counsel and Secretary

View Full Filing

View this 8-K filing on SEC EDGAR